Nanoviricides (NNVC) Non-Current Debt (2013 - 2023)

Nanoviricides has disclosed Non-Current Debt across 9 years of filings, most recently posting $1.5 million for Q3 2023.

• In Q3 2023, Non-Current Debt rose 6192.74% year-over-year to $1.5 million; the TTM figure through Sep 2023 stood at $1.5 million (up 6192.74% YoY), while the FY2023 annual figure was $1.5 million, up 1482.48% from the prior year.
• Non-Current Debt came in at $1.5 million for Q3 2023 at Nanoviricides, roughly flat from $1.5 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $1.5 million in Q2 2023 to a low of $15809.0 in Q3 2020.
• Average Non-Current Debt over 4 years is $341505.1, with a median of $95306.0 recorded in 2021.
• Year-over-year, Non-Current Debt fell 0.54% in 2022 and surged 6192.74% in 2023.
• Over 4 years, Non-Current Debt stood at $15809.0 in 2020, then jumped by 51.6% to $23967.0 in 2021, then slipped by 0.54% to $23837.0 in 2022, then surged by 6192.74% to $1.5 million in 2023.
• Per Business Quant data, the three most recent Non-Current Debt figures were $1.5 million in Q3 2023, $1.5 million in Q2 2023, and $23837.0 in Q3 2022.